ZA201401636B - Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator - Google Patents
Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulatorInfo
- Publication number
- ZA201401636B ZA201401636B ZA2014/01636A ZA201401636A ZA201401636B ZA 201401636 B ZA201401636 B ZA 201401636B ZA 2014/01636 A ZA2014/01636 A ZA 2014/01636A ZA 201401636 A ZA201401636 A ZA 201401636A ZA 201401636 B ZA201401636 B ZA 201401636B
- Authority
- ZA
- South Africa
- Prior art keywords
- solvates
- acid addition
- addition salts
- oxalic acid
- estrogen receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN665MU2013 IN2013MU00665A (en) | 2013-03-05 | 2014-03-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201401636B true ZA201401636B (en) | 2014-11-26 |
Family
ID=50382470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2014/01636A ZA201401636B (en) | 2013-03-05 | 2014-03-05 | Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator |
Country Status (3)
Country | Link |
---|---|
IN (1) | IN2013MU00665A (en) |
WO (1) | WO2014135834A1 (en) |
ZA (1) | ZA201401636B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2988620A1 (en) | 2015-06-16 | 2016-12-22 | Jiangsu Hengrui Medicine Co., Ltd. | Piperidine derivative and preparation method and pharmaceutical use thereof |
CN107428721B (en) | 2015-12-22 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | Benzopiperidine derivative, preparation method and medical application thereof |
MX2022008091A (en) | 2020-01-10 | 2022-07-11 | Jiangsu Hengrui Medicine Co | Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine. |
KR20240035515A (en) | 2021-07-09 | 2024-03-15 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | Salt form of triple ring tetrahydroisoquinoline derivative |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4358593A (en) | 1981-04-03 | 1982-11-09 | Eli Lilly And Company | Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes |
US4380635A (en) | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
TW366342B (en) | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
CO4410190A1 (en) | 1994-09-19 | 1997-01-09 | Lilly Co Eli | 3- [4- (2-AMINOETOXI) -BENZOIL] -2-ARIL-6-HYDROXYBENZO [b] CRYSTALLINE THIOPHEN |
US5629425A (en) * | 1994-09-19 | 1997-05-13 | Eli Lilly And Company | Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene |
CA2287918A1 (en) | 1997-04-30 | 1998-11-05 | John Mcneill Mcgill Iii | A regioselective alkylation process for preparing substituted benzo¬b|thiophenes |
WO2004029046A2 (en) | 2002-09-30 | 2004-04-08 | A/S Gea Farmaceutisk Fabrik | Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
SI2032521T1 (en) * | 2006-06-27 | 2010-02-26 | Sandoz Ag | New method for salt preparation |
GB2456096B (en) * | 2006-10-17 | 2011-08-17 | Cipla Ltd | Crystalline form of benzothiophene compound and process for preparation thereof |
WO2011099942A1 (en) | 2010-02-09 | 2011-08-18 | Silverstone Pharma | New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy |
-
2014
- 2014-03-05 ZA ZA2014/01636A patent/ZA201401636B/en unknown
- 2014-03-05 WO PCT/GB2014/000081 patent/WO2014135834A1/en active Application Filing
- 2014-03-05 IN IN665MU2013 patent/IN2013MU00665A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014135834A1 (en) | 2014-09-12 |
IN2013MU00665A (en) | 2015-07-03 |
WO2014135834A8 (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL281240A (en) | Androgen receptor modulator and uses thereof | |
IL275413A (en) | Crystalline forms of an androgen receptor modulator | |
HK1214532A1 (en) | Estrogen receptor modulator and uses thereof | |
HK1222101A1 (en) | Pouring device | |
GB201315630D0 (en) | Shuttering system | |
PL3068685T3 (en) | Fairlead for guiding an anchoring element | |
GB2529102B (en) | Improved printing of security devices | |
PL2895287T3 (en) | A combination of materials for mercury-dispensing devices and devices containing said combination of materials | |
IL240019A0 (en) | Estrogen receptor inhibitors | |
ZA201401636B (en) | Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator | |
IL244412A0 (en) | Liver x receptor (lxr) modulators | |
IL244418B (en) | Liver x receptor (lxr) modulators | |
IL249160A0 (en) | Crystalline forms of an estrogen receptor modulator | |
TH1401007292A (en) | Crystal form of androgen receptor modulator. |